- Medical cannabis company Khiron Life Sciences ( OTCQX:KHRNF ) said it looks forward to expand in Spain after the recent developments in the country relating to the regulation of medical cannabis.
- Spain has been an important exporter of medical cannabis in Europe, but the country has not had national medical cannabis legislation in place, according to the company.
- The potential market size for medical cannabis is estimated at least 700,000 patients or 1.5% of the country's total population, Khiron Life Sciences said.
- Source: Press Release
For further details see:
Khiron Life Sciences eyes expansion in Spain after recent developments on medical cannabis regulation